A population pharmacokinetic model for Cremophor EL using nonlinear mixed-effect modeling:: model building and validation

被引：1
|
作者：
Van Den Bongard, HJGD
Mathôt, RAA
Van Tellingen, O
Schellens, JHM
Beijnen, JH
机构：
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 EC Amsterdam, Netherlands
[2] Slotervaart Hosp, NL-1066 EC Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 53卷 / 05期
关键词：
D O I：
10.1046/j.1365-2125.2002.161316.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：552P / 553P
页数：2
相关论文
共 50 条
  • [1] A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling
    H. van den Bongard
    R. Mathôt
    O. van Tellingen
    J. Schellens
    J. Beijnen
    [J]. Cancer Chemotherapy and Pharmacology, 2002, 50 : 16 - 24
  • [2] A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling
    van den Bongard, HJGD
    Mathôt, RAA
    van Tellingen, O
    Schellens, JHM
    Beijnen, JH
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (01) : 16 - 24
  • [3] ALTERNATIVE APPROACHES TO ESTIMATION OF POPULATION PHARMACOKINETIC PARAMETERS - COMPARISON WITH THE NONLINEAR MIXED-EFFECT MODEL
    STEIMER, JL
    MALLET, A
    GOLMARD, JL
    BOISVIEUX, JF
    [J]. DRUG METABOLISM REVIEWS, 1984, 15 (1-2) : 265 - 292
  • [4] Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic models
    Haem, Elham
    Harling, Kajsa
    Ayatollahi, Seyyed Mohammad Taghi
    Zare, Najaf
    Karlsson, Mats O.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (01) : 55 - 66
  • [5] Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic models
    Elham Haem
    Kajsa Harling
    Seyyed Mohammad Taghi Ayatollahi
    Najaf Zare
    Mats O. Karlsson
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2017, 44 : 55 - 66
  • [6] Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model
    Padoin, C
    Tod, M
    Perret, G
    Petitjean, O
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) : 1463 - 1469
  • [7] A population pharmacokinetic model for docetaxel (Taxotere(R)): Model building and validation
    Bruno, R
    Vivier, N
    Vergniol, JC
    DePhillips, SL
    Montay, G
    Sheiner, LB
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1996, 24 (02): : 153 - 172
  • [8] Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models
    Botha, JH
    du Preez, M
    Miller, R
    Adhikari, M
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 53 (05) : 337 - 341
  • [9] Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models
    J. H. Botha
    M. J. du Preez
    R. Miller
    M. Adhikari
    [J]. European Journal of Clinical Pharmacology, 1998, 53 : 337 - 341
  • [10] A nonlinear mixed-effect mixture model for functional mapping of dynamic traits
    Hou, W.
    Li, H.
    Zhang, B.
    Huang, M.
    Wu, R.
    [J]. HEREDITY, 2008, 101 (04) : 321 - 328
12345